StockData
Marker Therapeutics, Inc. logo

Marker Therapeutics, Inc. (MRKR) stock

MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/30
$0.84+0.01 (+0.97%)

Close on Nov 17, 2026Market cap $13.95MP/E –Yield –

Marker Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Marker Therapeutics's price to book ratio was 1.3× on Nov 11, 2026, against 1.1× a year earlier. Over the last 5 years it ranged from 0.3× to 4.2×, with a median of 1.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.3×−0.0
2025Dec 31, 20251.4×−2.4
2024Dec 31, 20243.7×+0.8
2023Dec 29, 20232.9×+1.9
2022Dec 30, 20221.0×−0.5
2021Dec 31, 20211.5×−0.8
2020Dec 31, 20202.3×−0.5
2019Dec 31, 20192.7×−15.5
2018Dec 31, 201818.2×+11.3
2017Dec 29, 20176.9×+2.6
2016Dec 30, 20164.3×–

More Marker Therapeutics figures

See a number that looks wrong?